阿立哌唑与泰必利治疗儿童抽动障碍的对照研究

刘艳艳; 陈燕惠; 陈辉; 刘智胜

PDF(975 KB)

中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (06) : 421-424.

论著·临床研究

阿立哌唑与泰必利治疗儿童抽动障碍的对照研究

刘艳艳，陈燕惠，陈辉，刘智胜

作者信息 +

A control study of aripiprazole and tiapride treatment for tic disorders in children

LIU Yan-Yan, CHEN Yan-Hui, CHEN Hui, LIU Zhi-Sheng

Author information +

文章历史 +

摘要

目的：比较阿立哌唑与泰必利治疗儿童抽动障碍的疗效和安全性。方法：将65例6～14岁抽动障碍患儿随机分为两组，分别给予阿立哌唑(2.5~10 mg/d)与泰必利(25~400 mg/d)治疗，观察疗程12周后用《耶鲁综合抽动严重程度量表(YGTSS)评分表》评定临床疗效并观察不良反应。结果：从治疗第2周末起阿立哌唑组和泰必利组YGTSS总分得分均下降，但在第2周时阿立哌唑组下降率为（29±13）%，明显高于泰必利组下降率［（16±14）%,P<0.01］。治疗12周后，阿立哌唑组和泰必利组治疗总体有效率分别为91%和84%，差异无统计学意义。阿立哌唑组和泰必利组不良反应的发生率差异无统计学意义，且两组均未见严重不良反应。结论：小剂量阿立哌唑治疗儿童抽动障碍起效快、疗效好、有较好的安全性，为临床治疗儿童抽动障碍提供了一种新的药物选择。［中国当代儿科杂志，2010，12（6）：421-424］

Abstract

OBJECTIVE: To evaluate the efficacy and safety of aripiprazole in the treatment of tic disorder when tiapride is used as a control. METHODS: Sixty-five children aged 6-14 years old with tic disorders were randomly assigned to two groups: aripiprazole (2.5-10 mg/d) and tiapride treatment (25- 400 mg/d). After 12 weeks treatment, the clinical efficacy was assessed by the Yale Global Tie Severity Scale (YGTSS) score and the adverse reactions were observed. RESULTS: The YGTSS score in both groups decreased from the second week of treatment. Compared with the tiapride treatment group, the aripirazole treatment group showed a more decreased YGTSS score ［(29±13)% vs (16±14)%; P<0.01］ by the second week of treatment. The overall effective rate in the aripiprazole and tiapride treatment groups was 91% and 84%, respectively (P>0.05) 12 weeks after treatment. There were no significant differences in the incidence of adverse reactions between the aripiprazole and tiapride treatment groups and no severe adverse events were found in either group. CONCLUSIONS: Low dose aripiprazole is safe and effective for treatment of tic disorders in children, suggesting that it represents a new valid option for the treatment of tic disorder.［Chin J Contemp Pediatr, 2010, 12 (6):421-424］

导出引用

刘艳艳, 陈燕惠, 陈辉, 刘智胜. 阿立哌唑与泰必利治疗儿童抽动障碍的对照研究[J]. 中国当代儿科杂志. 2010, 12(06): 421-424

LIU Yan-Yan, CHEN Yan-Hui, CHEN Hui, LIU Zhi-Sheng. A control study of aripiprazole and tiapride treatment for tic disorders in children[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(06): 421-424

中图分类号： R748

参考文献

［1］陈会，钟佑泉，何志旭．儿童抽动障碍的免疫因素［J］．重庆医学, 2007, 36（20）：2107-2109．
［2］杜亚松，李华芳，钟佑泉，焦富勇，于得澧，王惠梅，等．可乐定透皮贴剂治疗抽动障碍的随机、双盲、安慰剂对照、多中心临床试验［J］．上海精神医学, 2006, 18（4）：193-198．
［3］吴仁容，李乐华．新型抗精神病药：阿立哌唑［J］．国外医学精神病学分册, 2004, 31(3)：177-179.
［4］Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis［J］. Prog Brain Res, 2008, 172:199-212.
［5］Seo WS, Sung HM, Sea HS, Bai DS. Aripiprazole treatment of children and dolescents with Tourette disorder or chronic Tic disorder［J］. J Child Adolesc Psychopharmacol, 2008, 18(2):197-205.
［6］Davies L, Stern JS, Agrawal N, Robertson MM. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole［J］. Hum Psychopharmacol, 2006, 21(7):447-453.
［7］Miranda CM, Castiglioni TC. Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients［J］. Rev Med Chil, 2007,135(6):773-776.
［8］American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) ［M］. Washington, DC:American Psychiatric Association, 2000:1-943.
［9］Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity［J］. J Am Acad Child Adolesc Psychiatry, 1989, 28(4): 566-573.
［10］Kane JM. Optimizing pharmacotherapy to maximize outcome in schizophrenia［J］. J Clin Psychiatry, 2005, 66(1):122133.
［11］Haupt DW. Differential metabolic effects of antipsychotic treatments［J］. Eur Europsychopharmacol, 2006, 16(s3):149-155.
［12］Ben Djebara M, Worbe Y, Schupbach M, Hartmann A. Aripiprazole: A Treatment for Severe Coprolalia in "Refractory" Gilles de la Tourette Syndrome［J］.Movement Disorders, 2008, 23(3):438-440.
［13］Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, et al. Case series on the use of aripiprazole for Tourette syndrome［J］. Int J Neuropsychopharmacol, 2005, 8(3):489-490.
［14］张彬，寇金爱．不同剂量阿立哌唑治疗精神分裂症的临床研究［J］. 中华临床医学研究杂志，2008，14(3)：310-311.